Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis

by Shanshan Huang, Jiawei Zheng, Yufang Huang, Li Song, Yin Yin, Danzhen Ou, Shangxiang He, Xiong Chen, Xuenong Ouyang
Published 2016-01-01

Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma

by Yin Yin, Xu Zhu, Shanshan Huang, Jiawei Zheng, Mengyun Zhang, Wencui Kong, Qun Chen, Yan Zhang, Xiong Chen, Kerong Lin, Xuenong Ouyang
Published 2017-05-01

Efficacy and Toxicity of Pemetrexed or Gemcitabine Combined with Cisplatin in the Treatment of Patients with Advanced Non-small Cell Lung Cancer

by Xingsheng HU, Shunchang JIAO, Shucai ZHANG, Zhehai WANG, Mengzhao WANG, Cheng HUANG, Rongsheng ZHENG, Kai LI, Jie WANG, Yajie WANG, Xuenong OUYANG, Wenguang LV, Gang CHENG, Chunhong HU, Rongcheng LUO, Yan SUN
Published 2012-10-01

CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: prom...

by Yuankai Shi, Jin Li, Jianming Xu, Yan Sun, Liwei Wang, Ying Cheng, Wei Liu, Guoping Sun, Yigui Chen, Li Bai, Yiping Zhang, Xiaohui He, Yi Luo, Zhehai Wang, Yunpeng Liu, Qiang Yao, Yuhong Li, Shukui Qin, Xiaohua Hu, Feng Bi, Rongsheng Zheng, Xuenong Ouyang
Published 2019-05-01